ATE89485T1 - Neurologisches therapiesystem. - Google Patents

Neurologisches therapiesystem.

Info

Publication number
ATE89485T1
ATE89485T1 AT90910077T AT90910077T ATE89485T1 AT E89485 T1 ATE89485 T1 AT E89485T1 AT 90910077 T AT90910077 T AT 90910077T AT 90910077 T AT90910077 T AT 90910077T AT E89485 T1 ATE89485 T1 AT E89485T1
Authority
AT
Austria
Prior art keywords
neurotransmitter
source
retrievable
neurological therapy
therapy system
Prior art date
Application number
AT90910077T
Other languages
English (en)
Inventor
Patrick Aebischer
Shelley R Winn
Original Assignee
Univ Brown Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Brown Res Found filed Critical Univ Brown Res Found
Application granted granted Critical
Publication of ATE89485T1 publication Critical patent/ATE89485T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/022—Artificial gland structures using bioreactors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0085—Brain, e.g. brain implants; Spinal cord
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/06—Head
    • A61M2210/0687—Skull, cranium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/06—Head
    • A61M2210/0693—Brain, cerebrum

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Eye Examination Apparatus (AREA)
  • Electrotherapy Devices (AREA)
  • Massaging Devices (AREA)
  • Saccharide Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT90910077T 1989-06-21 1990-06-20 Neurologisches therapiesystem. ATE89485T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36929689A 1989-06-21 1989-06-21
EP90910077A EP0478671B1 (de) 1989-06-21 1990-06-20 Neurologisches therapiesystem
PCT/US1990/003492 WO1990015637A2 (en) 1989-06-21 1990-06-20 Neurological therapy system

Publications (1)

Publication Number Publication Date
ATE89485T1 true ATE89485T1 (de) 1993-06-15

Family

ID=23454885

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90910077T ATE89485T1 (de) 1989-06-21 1990-06-20 Neurologisches therapiesystem.

Country Status (12)

Country Link
EP (1) EP0478671B1 (de)
JP (1) JP2738881B2 (de)
KR (1) KR0141583B1 (de)
AT (1) ATE89485T1 (de)
AU (1) AU632827B2 (de)
CA (1) CA2062746C (de)
DE (1) DE69001672T2 (de)
DK (1) DK0478671T3 (de)
ES (1) ES2058923T3 (de)
FI (1) FI916066A0 (de)
NO (1) NO300488B1 (de)
WO (1) WO1990015637A2 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5786216A (en) * 1987-11-17 1998-07-28 Cytotherapeutics, Inc. Inner-supported, biocompatible cell capsules
US5182111A (en) * 1987-11-17 1993-01-26 Boston University Research Foundation In vivo delivery of active factors by co-cultured cell implants
US5871472A (en) * 1987-11-17 1999-02-16 Brown University Research Foundation Planting devices for the focal release of neuroinhibitory compounds
US5773286A (en) * 1987-11-17 1998-06-30 Cytotherapeutics, Inc. Inner supported biocompatible cell capsules
US6517859B1 (en) 1990-05-16 2003-02-11 Southern Research Institute Microcapsules for administration of neuroactive agents
WO1991017772A1 (en) * 1990-05-16 1991-11-28 Southern Research Institute Controlled release dopamine and its use to stimulate nerve fiber growth
JPH06505186A (ja) * 1991-02-11 1994-06-16 オマーヤ，アユブ　ケー． 脊髄液駆動式人工器官
US5800829A (en) * 1991-04-25 1998-09-01 Brown University Research Foundation Methods for coextruding immunoisolatory implantable vehicles with a biocompatible jacket and a biocompatible matrix core
ATE156344T1 (de) * 1991-04-25 1997-08-15 Univ Brown Res Found Implantierbare, biokompatible immunisolator- trägersubstanz zum abgeben ausgesuchter, therapeutischer produkte
SG47451A1 (en) * 1991-06-28 1998-04-17 Univ Brown Res Found Implantable therapy system
CA2111978A1 (en) * 1991-06-28 1993-01-07 Patrick Aebischer Renewable neural implant device and method
US5383873A (en) * 1992-12-09 1995-01-24 Regents Of The University Of Minnesota Smooth muscle chemical pacemaker
WO1994015663A1 (en) * 1992-12-30 1994-07-21 Brown University Research Foundation Implantable therapy systems and methods
WO1995004521A1 (en) 1993-08-10 1995-02-16 W.L. Gore & Associates, Inc. Cell encapsulating device
WO1997010807A1 (en) * 1995-09-22 1997-03-27 Gore Hybrid Technologies, Inc. Improved cell encapsulation device
US6110707A (en) * 1996-01-19 2000-08-29 Board Of Regents, The University Of Texas System Recombinant expression of proteins from secretory cell lines
US6087129A (en) 1996-01-19 2000-07-11 Betagene, Inc. Recombinant expression of proteins from secretory cell lines
US6027721A (en) * 1996-05-20 2000-02-22 Cytotherapeutics, Inc. Device and method for encapsulated gene therapy
US6322962B1 (en) 1998-08-14 2001-11-27 Board Of Regents, The University Of Texas System Sterol-regulated Site-1 protease and assays of modulators thereof
US7745216B2 (en) 1999-02-10 2010-06-29 Curis, Inc. Methods and reagents for treating glucose metabolic disorders
US7396809B1 (en) 1999-02-10 2008-07-08 Curis, Inc. Methods and reagents for treating glucose metabolic disorders
EP2123293A3 (de) 2000-12-14 2010-09-08 Amylin Pharmaceuticals, Inc. Peptid YY und Peptid YY-Agonisten zur Behandlung von Stoffwechselstörungen
AUPR602401A0 (en) 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
AUPR602501A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release pharmaceutical composition
AUPR610501A0 (en) * 2001-07-04 2001-07-26 Smart Drug Systems Inc Treatment of parasitic disease
SI2561860T1 (en) 2002-05-31 2018-05-31 Titan Pharmaceuticals, Inc. An implantable polymeric device for prolonged release of buprenorphine
PT1610791E (pt) 2003-03-31 2011-05-23 Titan Pharmaceuticals Inc Dispositivo polim?rico implant?vel para liberta??o sustentada de agonista da dopamina
CA2526101A1 (en) * 2003-05-30 2004-12-23 Titan Pharmaceuticals, Inc. Implantable polymeric device for sustained release of nalmefene
US8603969B2 (en) 2004-02-11 2013-12-10 Amylin Pharmaceuticals, Llc Pancreatic polypeptide family motifs and polypeptides comprising the same
US7311861B2 (en) * 2004-06-01 2007-12-25 Boston Scientific Scimed, Inc. Embolization
JP2010252924A (ja) * 2009-04-22 2010-11-11 Olympus Corp カテーテルおよび薬剤投与装置
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8319766D0 (en) * 1983-07-22 1983-08-24 Graham N B Controlled release device
GB8403138D0 (en) * 1984-02-07 1984-03-14 Graham N B Sustained release of active ingredient
US4883666A (en) * 1987-04-29 1989-11-28 Massachusetts Institute Of Technology Controlled drug delivery system for treatment of neural disorders
US4892538A (en) * 1987-11-17 1990-01-09 Brown University Research Foundation In vivo delivery of neurotransmitters by implanted, encapsulated cells

Also Published As

Publication number Publication date
JP2738881B2 (ja) 1998-04-08
CA2062746A1 (en) 1990-12-22
WO1990015637A2 (en) 1990-12-27
EP0478671B1 (de) 1993-05-19
DE69001672T2 (de) 1993-12-23
AU632827B2 (en) 1993-01-14
DE69001672D1 (de) 1993-06-24
ES2058923T3 (es) 1994-11-01
CA2062746C (en) 1999-02-02
NO915074L (no) 1992-01-31
WO1990015637A3 (en) 1991-04-04
NO300488B1 (no) 1997-06-09
EP0478671A1 (de) 1992-04-08
KR0141583B1 (ko) 1998-06-15
NO915074D0 (no) 1991-12-20
FI916066A7 (fi) 1991-12-20
DK0478671T3 (da) 1993-10-18
AU5856590A (en) 1991-01-08
FI916066A0 (fi) 1991-12-20
JPH05500620A (ja) 1993-02-12

Similar Documents

Publication Publication Date Title
ATE89485T1 (de) Neurologisches therapiesystem.
DE59610355D1 (de) Medizinisches implantat
DK0540670T3 (da) Fremgangsmåde til fremstilling af tværbundne polyaminer
DE69631387D1 (de) Vorrichtung zur implantation von filamenten in den körper
SG48813A1 (en) Improved composition and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
AU5974096A (en) A device for delivering a preselected molecule into the system circulation
NO180031C (no) Anordning for in vivo avgivelse av neurotransmittere med implanterte, innkapslede celler
ATE172099T1 (de) Implantierte vorrichtung mit tumorzellen zur behandlung von krebs
HUP9902477A3 (en) Sustained delivery device and system of an active agent using an implantable system and method for producing of the device; a back-diffusion regulating outlet and a semipermeable plug
DK0528978T3 (da) Mikrokapsler til reguleret afgivelse og deres anvendelse i stimulering af nervefibervækst
CA2147626A1 (en) Cell Encapsulating Device
DK560186D0 (da) Kunstig kirtel til implantering i menneskekroppen
ATE334633T1 (de) Zahnprothese mit wirkstoffabgabevorrichtung
ZA87472B (en) System for delivering drug with enhanced bioacceptability
NZ331051A (en) Instant release forms of gelled active substances
AU7577091A (en) Process for the artificial stimulation of cells and cyte culture device
AU3681695A (en) Cell growth regulator
Carella et al. Eradication of the Philadelphia chromosome-positive clone and persistent restoration of normal polyclonal haemopoiesis in a chronic myelogenous leukemia patient after autologous transplant with peripheral blood Philadelphia-negative haemopoietic cells
ATE51512T1 (de) Klebstofflose gelenkpfannenkonstruktion fuer prothesen, sowie vorrichtung zur implantation.
MX9709828A (es) Linea celular que produce compuestos analgesicos para el tratamiento del dolor.
MX9700148A (es) Dispositivo implantable que contiene celulas de tumor para el tratamiento del cancer.
UA7269A (uk) Спосіб лікування хронічного алкоголізму
DZ1251A1 (fr) Cheveu artificiel pour implantation et aiguille pour son insertion dans le sous-cutane et le systèmerélatif pour la liaison au moyen de tous les noeuds connus.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee